MX363148B - Medicamento con una percepcion reducida de sabor amargo. - Google Patents

Medicamento con una percepcion reducida de sabor amargo.

Info

Publication number
MX363148B
MX363148B MX2016011172A MX2016011172A MX363148B MX 363148 B MX363148 B MX 363148B MX 2016011172 A MX2016011172 A MX 2016011172A MX 2016011172 A MX2016011172 A MX 2016011172A MX 363148 B MX363148 B MX 363148B
Authority
MX
Mexico
Prior art keywords
medication
bitter taste
taste perception
reduced bitter
polyquaternium
Prior art date
Application number
MX2016011172A
Other languages
English (en)
Other versions
MX2016011172A (es
Inventor
William Newlon Jason
Lin Yakang
Sreekrishna Koti
Christine Findley Molly
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2016011172A publication Critical patent/MX2016011172A/es
Publication of MX363148B publication Critical patent/MX363148B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/085Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41661,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un medicamento líquido con amargor reducido que contiene un ingrediente activo de fármaco y policuaternio-2, policuaternio-17 y/o policuaternio-18.
MX2016011172A 2014-02-27 2015-02-27 Medicamento con una percepcion reducida de sabor amargo. MX363148B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461945437P 2014-02-27 2014-02-27
US201462065843P 2014-10-20 2014-10-20
PCT/US2015/017895 WO2015131000A1 (en) 2014-02-27 2015-02-27 Medication with a reduced bitter taste perception

Publications (2)

Publication Number Publication Date
MX2016011172A MX2016011172A (es) 2016-12-16
MX363148B true MX363148B (es) 2019-03-11

Family

ID=52737387

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016011172A MX363148B (es) 2014-02-27 2015-02-27 Medicamento con una percepcion reducida de sabor amargo.

Country Status (10)

Country Link
US (2) US9592298B2 (es)
EP (1) EP3110396B1 (es)
CN (1) CN106061469A (es)
AU (1) AU2015222882B2 (es)
CA (1) CA2937761A1 (es)
ES (1) ES2687257T3 (es)
MX (1) MX363148B (es)
PL (1) PL3110396T3 (es)
RU (1) RU2666531C2 (es)
WO (1) WO2015131000A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110302149A (zh) * 2019-08-07 2019-10-08 北京博达绿洲医药科技研究有限公司 一种适合4-11岁儿童服用抗感冒药物及其制备方法
CN110327339A (zh) * 2019-08-07 2019-10-15 北京博达绿洲医药科技研究有限公司 一种复方右美沙芬口服溶液及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763449A (en) * 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
DE10022077A1 (de) * 2000-05-06 2001-11-08 Henkel Kgaa Kosmetisches Mittel enthaltend 2-Furanonderivate
US20060024335A1 (en) * 2004-07-29 2006-02-02 Roger Stier E Oral compositions which mask the bitter taste of a bitter-tasting agent
US8450378B2 (en) * 2006-02-09 2013-05-28 Gojo Industries, Inc. Antiviral method
DE102010031291A1 (de) * 2010-07-13 2012-01-19 Henkel Ag & Co. Kgaa Zahnweißende Mundwasser und Mundwasserkonzentrate
EP2641477B2 (de) 2012-03-19 2022-06-08 Symrise AG Stoffgemische

Also Published As

Publication number Publication date
RU2666531C2 (ru) 2018-09-11
WO2015131000A1 (en) 2015-09-03
EP3110396B1 (en) 2018-07-04
AU2015222882B2 (en) 2017-06-22
PL3110396T3 (pl) 2018-11-30
AU2015222882A1 (en) 2016-08-04
ES2687257T3 (es) 2018-10-24
EP3110396A1 (en) 2017-01-04
MX2016011172A (es) 2016-12-16
US9592298B2 (en) 2017-03-14
CN106061469A (zh) 2016-10-26
RU2016131398A (ru) 2018-02-01
US20150238612A1 (en) 2015-08-27
CA2937761A1 (en) 2015-09-03
US20170136126A1 (en) 2017-05-18

Similar Documents

Publication Publication Date Title
HK1250223A1 (zh) 傳感器、藥筒和藥物輸送裝置
EP3151891A4 (en) Liquid drug cartridges and associated dispenser
EP3374901A4 (en) PUSH ALARMS AT INFUSION
EP3302265A4 (en) Drug delivery capsule
EP3146854A4 (en) Flavor inhaler and cup member
EP3375427A4 (en) Drug mixer, hard dual-port member, and soft infusion bag
MX2016011170A (es) Composiciones para el cuidado bucal con una percepcion reducida de sabor amargo.
MX2016011171A (es) Composiciones con una percepcion reducida de sabor amargo.
EP3272776A4 (en) Copolymer, ink containing same, and ink container
EP3178028A4 (en) Medication dispensing phone case
EP3466452A4 (en) FRAGRANCE-RELEASING MODULE AND FRAGRANCE-RELEASING CONTAINER THEREFOR
EP3141079A4 (en) Wireless sensor system with dynamic heartbeat message rate
EP3639677A4 (en) INGREDIENTS LIQUID FLAVORING AGENTS
SG11201600023QA (en) Medicine container, method of assembling the container, and method of dispensing the medicine from the container
EP3513662A4 (en) LIQUID SEASONING CONTAINING INGREDIENTS
EP3235488A4 (en) Port, and drug solution bag
MX2016011172A (es) Medicamento con una percepcion reducida de sabor amargo.
EP3434252A4 (en) RUBBER STOPPER FOR MEDICINAL CONTAINER, MEDICINAL CONTAINER FOR RECEIVING MEDICINAL PRODUCT AND MEDICINAL CONTAINER ASSEMBLY
EP3127544A4 (en) Anti-tumor drug containing anti-tumor platinum complex, and anti-tumor effect enhancer
EP3434251A4 (en) DRUGS CONTAINER
EP3466548A4 (en) DISPENSER AND DISPENSER AND CARTRIDGE
HRP20181943T1 (hr) Spremnik za lijekove, postupak sklapanja spremnika, i postupak izdavanja lijeka iz spremnika
刘伟伟 et al. VEGF
PH22014000280Y1 (en) An improved teether
Fang You Asked We Answered